Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
24.55B | 22.57B | 20.45B | 18.25B | 17.68B | 18.02B | Gross Profit |
5.77B | 5.27B | 4.81B | 4.38B | 3.90B | 4.00B | EBIT |
3.23B | 2.81B | 2.54B | 2.23B | 1.87B | 1.94B | EBITDA |
3.52B | 3.28B | 3.31B | 2.54B | 2.09B | 2.05B | Net Income Common Stockholders |
2.41B | 2.11B | 2.21B | 1.63B | 1.36B | 1.27B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
15.88B | 14.19B | 13.05B | 11.85B | 11.13B | 8.97B | Total Assets |
27.43B | 26.23B | 24.02B | 21.90B | 20.68B | 19.26B | Total Debt |
360.00M | 17.02M | 23.28M | 16.82M | 21.30M | 29.36M | Net Debt |
-15.52B | -14.17B | -13.03B | -11.83B | -11.11B | -8.82B | Total Liabilities |
6.47B | 6.52B | 6.11B | 5.80B | 5.50B | 5.67B | Stockholders Equity |
20.96B | 19.71B | 17.91B | 16.10B | 15.17B | 13.59B |
Cash Flow | Free Cash Flow | ||||
0.00 | 1.79B | 2.05B | 1.58B | 2.01B | 838.16M | Operating Cash Flow |
0.00 | 1.85B | 2.09B | 1.65B | 2.12B | 1.11B | Investing Cash Flow |
0.00 | -121.89M | -1.21B | -318.93M | 354.53M | -881.67M | Financing Cash Flow |
0.00 | -582.60M | -267.83M | -617.69M | -258.77M | -250.47M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥34.69B | 15.31 | 2.98% | 11.00% | 33.93% | ||
77 Outperform | ¥26.27B | 10.92 | 1.18% | 11.94% | 14.10% | ||
74 Outperform | ¥1.31T | 29.10 | 1.69% | 24.10% | 11.27% | ||
72 Outperform | $637.47B | 33.20 | 13.64% | 0.43% | 6.92% | 25.38% | |
71 Outperform | ¥1.11T | 19.75 | 16.17% | 2.58% | 15.49% | 18.42% | |
62 Neutral | $11.80B | 10.31 | -7.45% | 2.91% | 7.43% | -7.78% |